Hunger Hormones
Binge Eating and Appetite Signals
Binge eating is distinct from ordinary overeating, with its own recognisable pattern and appetite signalling disruption....
5-HTP is unusual in this category. Most supplements here have weak evidence for a plausible mechanism. 5-HTP has reasonably positive evidence from genuinely small trials, for a mechanism that is well understood and has a difficult history.
It also carries the most serious drug interaction of anything covered in this series.
What 5-HTP is
5-HTP is 5-hydroxytryptophan, a compound your body makes from the amino acid tryptophan. It is the direct precursor to serotonin, a neurotransmitter involved in mood, sleep and appetite.
The supplement is extracted from the seeds of *Griffonia simplicifolia*, a West African shrub.
Unlike tryptophan, 5-HTP crosses the blood-brain barrier readily and converts to serotonin without a rate-limiting step. Taking it raises brain serotonin fairly directly.
Why serotonin affects appetite
Serotonin has a well-established role in satiety. Higher serotonin signalling in specific brain regions reduces food intake, and it appears to have a particular effect on carbohydrate intake.
This is not a fringe theory. A review of serotonin drugs and appetite, available on PubMed, sets out that 5-HT drugs reduce appetite both before and after fixed caloric loads, and reduce pre-meal appetite and intake at freely eaten meals.
The mechanism is real enough that pharmaceutical companies built weight loss drugs on it.
What the trials found
A double-blind randomised trial, available on PubMed, assigned 20 people with obesity to 5-HTP at 900 mg daily or placebo across two consecutive six-week periods.
Significant weight loss occurred in the 5-HTP group in both periods, alongside reduced carbohydrate intake and consistent early satiety, meaning participants felt full sooner during meals.
Further small trials have examined *Griffonia simplicifolia* extract, including sublingual spray formulations, in overweight women over four to eight weeks. These reported improved satiety during a reduced calorie diet.
The findings are consistent in direction. The problem is scale.
The size problem
These trials involve roughly 20 to 27 participants each.
That is very small. Small trials overestimate effects more often than they underestimate them, and they cannot detect uncommon harms at all. A supplement with promising results in 20 people is at the stage where a proper trial is warranted, not at the stage where conclusions are settled.
Compare this with the evidence base elsewhere in this series. The glucomannan finding pooled 67 trials. The L-carnitine finding pooled 37 with 2,292 participants. The meal replacement finding covered 7,884 people.
5-HTP has nothing at that scale. It is promising and unproven, which is a genuinely different position from either "it works" or "it does not."
The serotonin drug history
This context matters for judging the mechanism.
Fenfluramine, part of the fen-phen combination, worked through serotonin and produced real weight loss. It was withdrawn in 1997 after being linked to heart valve damage and pulmonary hypertension.
Sibutramine, which acted on serotonin and noradrenaline, was withdrawn worldwide in 2010 after trial evidence of increased cardiovascular risk.
Lorcaserin, a more selective serotonin receptor agonist, was withdrawn in 2020 over a cancer signal.
Three serotonergic weight loss drugs, three withdrawals. The mechanism works and it has repeatedly proven difficult to make safe over long-term use.
5-HTP is a supplement rather than any of those drugs, and it should not be equated with them. But a category with that safety record deserves caution rather than enthusiasm, particularly at 900 mg daily over months.
The interaction that matters most
Do not combine 5-HTP with SSRIs, SNRIs, MAOIs, tramadol, triptans for migraine, or any other serotonergic medication without medical supervision.
The risk is serotonin syndrome, caused by excessive serotonin activity. Symptoms range from agitation, rapid heart rate, sweating, tremor and dilated pupils through to high fever, muscle rigidity, seizures and, in severe cases, death.
This is not a theoretical caution. Antidepressant use is common, and people frequently do not think of a supplement as a drug interaction risk.
If you take any antidepressant, or any medication affecting serotonin, 5-HTP is not something to add on your own initiative. If you experience agitation, confusion, rapid heartbeat, sweating or muscle twitching after starting it, stop and speak with a specialist urgently.
Other cautions
Carbidopa combination. Some research uses 5-HTP with carbidopa to prevent conversion to serotonin outside the brain. Case reports have linked this combination to scleroderma-like skin changes.
Contamination history. In 1989 an outbreak of eosinophilia-myalgia syndrome, a serious and sometimes fatal condition, was linked to contaminated L-tryptophan supplements. 5-HTP is a different compound and modern production differs, but the episode is a reminder of what unregulated supplement manufacturing can produce.
Common side effects include nausea, which is frequent at higher doses, along with drowsiness, heartburn and digestive discomfort.
Not for pregnancy or breastfeeding, and not for children.
Surgery. Serotonergic compounds should generally be stopped before surgery due to interaction with anaesthetic agents.
5-HTP in Pakistan
5-HTP is sold here through online supplement sellers and some retailers, usually imported and often within multi-ingredient formulations.
Two concerns compound in this market.
The interaction risk is invisible to the buyer. Nobody at the point of sale asks what medication you take. Antidepressant prescriptions are increasingly common, and a customer buying an appetite supplement has no prompt to consider serotonin syndrome.
The quality question applies as it does to every supplement here. WHO estimates at least 1 in 10 medical products in low- and middle-income countries are substandard or falsified, and supplements face less scrutiny than medicines.
The honest summary is that 5-HTP has a real mechanism, small positive trials and a serious interaction that is not adequately communicated by the way it is sold.
If appetite is the problem you are trying to solve, the safer route is one where somebody medically qualified reviews what else you are taking first. METASLIM™ physician-guided drops include exactly that review before dispatch, as a physician-reviewed sublingual supplement working on the GLP-1 pathway rather than the serotonin system. It is not a pharmaceutical GLP-1 receptor agonist and injectable trial figures do not apply to it. What differs from buying 5-HTP online is that a physician screens your medication list, which is precisely the step that prevents a serotonin interaction going unnoticed.
Our guides to chromium and protein for weight loss cover other approaches to appetite.
The verdict
5-HTP raises brain serotonin, and serotonin genuinely reduces appetite, particularly carbohydrate intake.
Small randomised trials, mostly around 20 participants, found reduced appetite, early satiety and weight loss.
The evidence base is far too small to be conclusive, and nothing exists at the scale of the pooled analyses covering other supplements.
Three pharmaceutical serotonergic weight loss drugs have been withdrawn for safety over three decades.
The interaction risk with antidepressants and other serotonergic drugs is serious and potentially life-threatening.
Get started with a physician review rather than adding a serotonergic supplement without one.
This article is for informational purposes only and does not constitute medical advice. Consult a qualified physician before starting any weight loss program, medication, or supplement.